力蜚能治疗小儿缺铁性贫血的疗效观察  

Observation on the Curative Effect of Polysaccharide Iron Complex to Treat Children's Iron Deficiency Anemia

作　　者：梁荣伟[1] 

机构地区：[1]南方医科大学广济医院儿科,广东东莞523690

出　　处：《医学信息（西安上半月）》2007年第10期1810-1812,共3页Medical Information

摘　　要：目的探讨多糖铁复合物力蜚能治疗小儿缺铁性贫血的疗效观察。方法60例患儿随机分为力蜚能治疗组和硫酸亚铁治疗组,前者给予力蜚能治疗;后者给予硫酸亚铁和维生素C治疗。结果治疗8周后力蜚能治疗组的血清铁(SI)水平明显高于硫酸亚铁治疗组(P<0.01);力蜚能治疗组的总有效率高于硫酸亚铁治疗组(P<0.05),且不良反应有显著性差异(P<0.01)。结论力蜚能治疗小儿缺铁性贫血的疗效优于硫酸亚铁,且不良反应少,是治疗小儿缺铁性贫血的理想药物。Objective To observe the curative effect of polysaccharide iron complex （PIC, Niferex） to treat children＇s iron deficiency anemia （IDA）. Methods 60 children with IDA were randomly divided into two groups： the Niferex and Irosul treated groups. The former were treated with Niferex, and the latter with Irosul combined vitamin C. And then observe the Hb, RBC and SI of the two groups. Results Treated for 8 weeks, the SI of Niferex treated group were significantly higher than that of Irosul treated group （P〈 0.01）, besides, the total effective ratio of former group were higher than the latter （93.33% vs 73.33%, P〈0.05）, and the ratio of adverse effect were significantly lower than the latter （P〈0.01）. Conclusion The curative effect of Niferex to treat children＇s IDA is better than that of Irosul, and its adverse effect is lower, which is an excellent medicine to treat the disease.

关 键 词：缺铁性贫血 多糖铁复合物 硫酸亚铁 

分 类 号：R151[医药卫生—营养与食品卫生学]